Aller au contenu principal
Profil bibliographique

Simone Tortoioli

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

46Publications signalées
815Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Chemical Synthesis and ReactionsSulfur-Based Synthesis TechniquesAsymmetric Synthesis and CatalysisSynthesis and Catalytic ReactionsSynthetic Organic Chemistry Methods

Les publications récentes

2026 conference-abstract OpenAlex

Abstract B044: Targeting the “undruggable” oncogene CCNE1 using a molecular glue degrader in CCNE1 amplified cancers

William Tahaney, Yimao Liu, Ahmed Abdullah, Vittoria Massafra et autres

Abstract Using our QuEENTM molecular glue degrader (MGD) discovery engine that integrates biochemical and cellular assays with in silico modeling, we identified and optimized MGDs that induce proteasomal degradation of cyclin E1 (CCNE1) as a therapeutic strategy for CCNE1-amplified cancers. We generated …

us, ch (code pays fourni par la source)

0 citations Clinical Cancer Research
2026 conference-abstract OpenAlex

Abstract PR003: Targeting the “undruggable” oncogene CCNE1 using a molecular glue degrader in CCNE1 amplified cancers

William Tahaney, Yimao Liu, Ahmed Abdullah, Vittoria Massafra et autres

Abstract Using our QuEENTM molecular glue degrader (MGD) discovery engine that integrates biochemical and cellular assays with in silico modeling, we identified and optimized MGDs that induce proteasomal degradation of cyclin E1 (CCNE1) as a therapeutic strategy for CCNE1-amplified cancers. We generated …

us, ch (code pays fourni par la source)

0 citations Clinical Cancer Research
2023 conference-abstract OpenAlex

Abstract ND10: Discovery of MRT-2359, an orally bioavailable GSPT1 molecular glue degrader, for MYC-driven cancers

Owen B. Wallace, Gérald Gavory, Mahmoud Ghandi, Anne-Cecile d’Alessandro et autres

Abstract MYC transcription factors have been demonstrated to be drivers of many cancers, yet have remained recalcitrant to new drug development. We hypothesized that MYC-driven cancer cell lines are addicted to protein translation, and therefore are vulnerable to the loss of the …

ch (code pays fourni par la source)

5 citations Cancer Research
2023 conference-abstract OpenAlex

Abstract 3449: Development of MRT-2359, an orally bioavailable GSPT1 molecular glue degrader, for the treatment of lung cancers with MYC-induced translational addiction

Gérald Gavory, Mahmoud Ghandi, Anne-Cecile d’Alessandro, Débora Bonenfant et autres

Abstract MYC transcription factors are well-established drivers of human cancers but despite being amongst the most frequently altered oncogenes, no approved therapy targeting MYC-driven tumors has been developed to date. MYC-driven cancers are known to be addicted to protein translation. This addiction …

us (code pays fourni par la source)

17 citations Cancer Research
2022 conference-abstract OpenAlex

Abstract 3929: Identification of MRT-2359 a potent, selective and orally bioavailable GSPT1-directed molecular glue degrader (MGD) for the treatment of cancers with Myc-induced translational addiction

Gérald Gavory, Mahmoud Ghandi, Anne-Cecile d’Alessandro, Débora Bonenfant et autres

Abstract Myc transcription factors are well-established drivers of human cancers. However, despite being amongst the most frequently mutated, translocated and overexpressed oncogenes, no therapy targeting the Myc family members directly has been developed to date. To sustain uncontrolled cell proliferation and tumor …

ch (code pays fourni par la source)

27 citations Cancer Research
Accès ouvert 2020 preprint OpenAlex

Development of an Efficient and Sustainable Synthesis of 2-(3-Methyl-1H-1,2,4-Triazol-1-Yl) Acetic Acid Under Continuous-Flow Conditions

Simone Tortoioli, Astrid Friedli, Alice Prud’homme, Sylvia Richard‐Bildstein et autres

A novel, metal-free process for the challenging synthesis of 2-(3-methyl-1 H -1,2,4-triazol-1-yl) acetic acid ( 1 ) is reported, which features an efficient condensation for the triazole build-up under flow conditions. This continuous, two-step method is atom economical, highly selective and environmentally …

it (code pays fourni par la source)

0 citations ChemRxiv
Accès ouvert 2020 preprint OpenAlex

Development of an Efficient and Sustainable Synthesis of 2-(3-Methyl-1H-1,2,4-Triazol-1-Yl) Acetic Acid Under Continuous-Flow Conditions

Simone Tortoioli, Astrid Friedli, Alice Prud’homme, Sylvia Richard‐Bildstein et autres

A novel, metal-free process for the challenging synthesis of 2-(3-methyl-1H-1,2,4-triazol-1-yl) acetic acid (1) is reported, which features an efficient condensation for the triazole build-up under flow conditions. This continuous, two-step method is atom economical, highly selective and environmentally benign, due to the …

it (code pays fourni par la source)

0 citations ChemRxiv
Accès ouvert 2020 article OpenAlex

Development of an efficient and sustainable synthesis of 2-(3-methyl-1 H -1,2,4-triazol-1-yl) acetic acid under continuous-flow conditions

Simone Tortoioli, Astrid Friedli, Alice Prud’homme, Sylvia Richard‐Bildstein et autres

A novel, metal-free process for the challenging synthesis of 1,2,4-triazoles is reported, which features an efficient construction of the triazole ring under flow conditions.

ch, us, cn (code pays fourni par la source)

17 citations Green Chemistry
2018 article OpenAlex

One-Pot Synthesis of Trifluoromethylated Quinazolin-4(3H)-ones with Trifluoroacetic Acid as CF3 Source

Sofia Almeida, Roger Martí, Ennio Vanoli, Stefan Abele et autres

A novel and convenient one-pot sequential cascade method for the preparation of 2-trifluoromethylquinazolin-4(3 H )-ones is described. Trifluoroacetic acid (TFA) was employed as inexpensive and readily available CF 3 source, which in the presence of T3P was condensed with a variety of …

ch (code pays fourni par la source)

23 citations The Journal of Organic Chemistry
Accès ouvert 2016 article OpenAlex

Cover Picture: Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold‐Hopping Approach (ChemMedChem 19/2016)

Bibia Heidmann, John Gatfield, Catherine Roch, Alexander Treiber et autres

The front cover picture shows the successful application of a scaffold-hopping approach starting from the upper model structure and replacing the central core with different bicyclic diamine templates (some representative templates are depicted above the funnel). The structure–activity relationship optimizations (represented by …

ch (code pays fourni par la source)

0 citations ChemMedChem
2016 article OpenAlex

Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold‐Hopping Approach

Bibia Heidmann, John Gatfield, Catherine Roch, Alexander Treiber et autres

Starting from suvorexant (trade name Belsomra), we successfully identified interesting templates leading to potent dual orexin receptor antagonists (DORAs) via a scaffold-hopping approach. Structure-activity relationship optimization allowed us not only to improve the antagonistic potency on both orexin 1 and orexin 2 …

ch (code pays fourni par la source)

22 citations ChemMedChem

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.